Pharmaxis Ltd |
High $0.05 |
Low $0.04 |
Trades 74 |
Turnover $48,318 |
Volume 1,094,468 |
| 30 June 2023 at 4:10pm | ||||
|
Market Cap (14-Nov) $19,510,578 (1,113th) |
Close (30-Jun) $0.049 |
Volume (30-Jun) 1,094,468 |
Shortsold (12-Jul) 1 (0.00%) (672nd) |
|
52w High $0.000 |
52w Low $0.000 |
P/E 20.45 |
EPS -0.02 |
Appendix 2A - Exercise of Employee Options
PXS released this announcement to the ASX on 15 February 2021, 12:07. The announcement is not marked as price sensitive, and is 15 page(s) in length and 193.44kb in size.
You can view all announcements from PXS and see how they appear on a price chart on the announcements page.
At the date of this announcement, PXS was 0.000% short sold according to ASIC data. It was ranked the 626th most shorted stock on the ASX. It remains ranked 672nd as of the latest reported data (12 July 2023).
| Other Recent Announcements from PXS | |
|---|---|
| Investor presentation | 24 May 2023, 8:21 |
| PXS Announces Encouraging Results from Phase 1c Scar Study | 23 May 2023, 16:32 |
| Trading Halt | 22 May 2023, 8:56 |
| Appendix 2A - Exercise of Employee Options | 15 February 2021, 12:07 |
| Half Yearly Report and Accounts | 10 February 2021, 17:39 |
| Pharmaxis Exports CF Drug to US - US$3 Million Milestone | 9 February 2021, 8:45 |
| Appendix 4C - quarterly | 29 January 2021, 8:50 |
If you were already registered, log in here.